738 Spurious Drugs Cases, 528 Put On Back Burner

Jaipur: The previous Congress government was apparently very kind to the traders selling death in name of medicine. The situation was such that during these five years, Dept. to control spurious medicines found 738 medicines to be of substandard grade in sample testing, but legal action was taken and challan presented only in 90 cases.

Laxity was shown in taking action against firms related to 89 medicines which were directly found to be fake in sample test. Of these, investigation of 64 medicines has not been completed till now while complaints filed only in 25 out of 89 cases.

The slow pace of probe during Cong govt points towards a nexus between govt machinery and pharma firms. In previous govt, responsibility of Drugscontrol Dept. was first with Raghu Sharma and later with Parsadilal Meena. However, pace of probe in these cases remained the same.

Related Posts

  • Pharma
  • January 2, 2025
  • 29 views
Kwality Pharma gains on securing RCGM approval for Erythropoietin

Kwality Pharmaceuticals rose 3.19% to Rs 895 after the company secured approval from the Review Committee on Genetic Manipulation (RCGM) to begin pre-clinical toxicity studies for the recombinant Erythropoietin product,…

  • Pharma
  • January 2, 2025
  • 245 views
Sun Pharma sells entire stake in Japanese arm to Zaza Industrial Holdings

Sun Pharmaceutical Industries has announced the 100 per cent sale of its step-down subsidiary, Sun Pharma Japan Technical Operations, to Zaza Industrial Holdings K.K., Japan. The decision marks a strategic…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Kwality Pharma gains on securing RCGM approval for Erythropoietin

Kwality Pharma gains on securing RCGM approval for Erythropoietin

Man held with drugs worth Rs 2.50 cr, planned for New Year supply in Bengaluru

Man held with drugs worth Rs 2.50 cr, planned for New Year supply in Bengaluru

Sun Pharma sells entire stake in Japanese arm to Zaza Industrial Holdings

Sun Pharma sells entire stake in Japanese arm to Zaza Industrial Holdings

Bliss GVS Pharma Reaches 52-Week High of Rs. 181.35 with 42.53% Annual Return

Bliss GVS Pharma Reaches 52-Week High of Rs. 181.35 with 42.53% Annual Return

New Pharma Rules In India Effective Today: Are MSMEs Ready? What Will Change For The Industry

New Pharma Rules In India Effective Today: Are MSMEs Ready? What Will Change For The Industry

Sun Pharma To Sell 100 Percent Stake In Japanese Arm

Sun Pharma To Sell 100 Percent Stake In Japanese Arm